Indraprastha Medical Corporation Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 11.26% vs 4.94% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 8.53% vs 14.94% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 9.10% vs 8.98% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is 5.77% vs -3.11% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Indrapr.Medical With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

406.15

282.01

124.14

44.02%

Other Operating Income

0.00

Total Operating income

406.15

282.01

124.14

44.02%

Raw Material Cost

70.13

0.00

70.13

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

72.96

41.76

31.20

74.71%

Power Cost

0.00

Manufacturing Expenses

111.15

165.19

-54.04

-32.71%

Selling and Distribution Expenses

0.00

Other Expenses

72.10

19.57

52.53

268.42%

Total Expenditure (Excl Depreciation)

326.34

226.52

99.82

44.07%

Operating Profit (PBDIT) excl Other Income

79.81

55.49

24.32

43.83%

Other Income

8.42

5.40

3.02

55.93%

Operating Profit (PBDIT)

88.23

60.89

27.34

44.90%

Interest

1.65

6.42

-4.77

-74.30%

Exceptional Items

0.00

Gross Profit (PBDT)

86.58

54.47

32.11

58.95%

Depreciation

11.76

12.35

-0.59

-4.78%

Profit Before Tax

74.82

42.11

32.71

77.68%

Tax

18.97

11.06

7.91

71.52%

Provisions and contingencies

0.00

Profit After Tax

55.85

31.05

24.80

79.87%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

55.85

31.05

24.80

79.87%

Equity Capital

91.67

15.83

75.84

479.09%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

6.09

1.96

4.13

210.71%

Diluted Earnings per share

6.09

1.96

4.13

210.71%

Operating Profit Margin (Excl OI)

19.65%

19.68%

0.00

-0.03%

Gross Profit Margin

21.32%

19.31%

0.00

2.01%

PAT Margin

13.75%

11.01%

0.00

2.74%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 406.15 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 11.33% vs -1.83% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 11.26% vs 4.94% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 55.85 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 33.93% vs 1.71% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 8.53% vs 14.94% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 79.81 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 31.90% vs -2.32% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 9.10% vs 8.98% in Jun 2025

Quarterly - Interest

Interest 1.65 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 10.74% vs 2.05% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 5.77% vs -3.11% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.65%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025